Pain Therapeutics reported $-17527000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US $ 2447M 458M
Acelrx Pharmaceuticals ACRX:US $ -8.67M 0.76M
Acura Pharmaceuticals ACUR:US -387000 128K
Amgen AMGN:US $ 1476M 423M
Biogen BIIB:US $ 303.8M 64.4M
Cara Therapeutics CARA:US $ -27749000 5.63M
Eisai 4523:JP Y -12403M 26575M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Geron GERN:US $ -30.1M 1.92M
Johnson & Johnson JNJ:US $ 5149M 413M
Merk MRK:US $ 4310M 552M
Novartis NOVN:VX SF 2222M 14086M
Novavax NVAX:US $ 203.41M 1049.69M
Pain Therapeutics PTIE:US $ -17.53M 3.36M
Pfizer PFE:US $ 7863M 4470M